*Longevity biotech NewLimit accelerates to clinic after finding age-reprogramming target ahead of schedule.*
As of THU, JUN 4, 11:28 AM · New Brief Daily
Last updated June 4, 2026 — I read this morning's peptide research and picked the items that mattered. Fresh brief tomorrow.
*Longevity biotech NewLimit accelerates to clinic after finding age-reprogramming target ahead of schedule.*
Research VialsComplete guide to research chemicals and peptides for metabolic studies in 2026. Compound profiles, mechanism comparisons, protocol design, and sourcing information.
PubMed · BMJ open diabetes research & careViolante-Ortiz R et al., BMJ open diabetes research & care · 2026 Mar 30. PMID 41912265.
Peter AttiaPeter Attia reviews the research on growth hormone for adult tissue repair. Despite a clear mechanism, the clinical evidence hasn't backed the hype — a sober read for anyone tracking GH secretagogue literature.
Lifespan.ioThe Forever Healthy Foundation has launched evipedia.ai — a free, public encyclopedia covering more than 500 health and longevity interventions. It includes first-generation rejuvenation therapies, supplements, and lifestyle protocols.
Longevity TechnologyA new $400 million initiative will combine human brain tissue, AI, and open science to probe the cellular roots of Alzheimer's, Parkinson's, ALS, and Huntington's. The project bets that open data sharing can move faster than proprietary drug programs.
Longevity TechnologyAEON Clinic is now offering NAD+ (a compound studied for cellular energy and aging) IV therapies in Dubai. The launch reflects growing demand for personalized longevity medicine outside traditional Western markets.
The Enhanced ManDiscover the latest breakthroughs in longevity medicine, particularly with tadalafil, a medication commonly known by its brand name cialis, which has been widely used to treat erectile dysfunction in men. Recent studies have shed new light
Dr Jones DCBook your free discovery call *HERE:* https://drjonesdc.com/yt1d Most experienced GLP-1 users think they’re making smart moves, but some of the most common “best practices” can backfire hard. I’m sharing the five mistakes I see again and
Cortex Labs40% discount on downloadable products/courses/guides. Enter code: "40now" at checkout! 💥🚀 Hire me to resolve Libido/EQ/Sensation issues on TRT, HRT, or from the use of 5-AR inhibitors. 💥🚀 📞 🧨💣 Book 1 on 1 coaching with Ryan, and so
Regan ArchibaldStruggling with low energy, poor metabolic health, or wondering when the best time is to take MOTS-c peptide for maximum results? In this video, I explain the science behind MOTS-c, the ideal timing strategies, why cycling matters, and when
Dr Trevor BachmeyerDementia & Alzheimer’s Are Reversible - The Mitochondria, Insulin Resistance, and Inflammation Protocol In this episode, I explain that dementia, Alzheimer’s, and cognitive decline are largely preventable and often reversible, and I critic
Dr Debra DurstIf Viagra or Cialis hasn't been giving you the results you expected or if your drive just feels off, the problem might not be your blood flow at all. It might be your brain. In this episode, Dr. Debra Durst breaks down PT-141 (bremelanotid
Tim FerrissJake Becraft is the CEO and co-founder of Strand Therapeutics, a company building one of the most advanced programmable genetic medicine platforms in biotechnology. Under his leadership, Strand is redefining what RNA medicines can do by ena
Regan ArchibaldStruggling with stubborn body fat, low energy, or poor metabolic health despite your best efforts? In this video, I explain what 5-Amino-1MQ is, how it works by inhibiting the NNMT pathway, and the research behind its potential impact on fa
Thomas DeLauerJoin Thrive Market today and get $20 off your first three orders plus a free $60 gift! http://thrivemarket.com/ThomasDeLauer This video does contain a paid partnership with a brand that helps to support this channel. It is because of brand
Research VialsComprehensive research profile of retatrutide, the GLP-1/GIP/glucagon triple receptor agonist. Phase 2 data, mechanism of action, and research compound guide.
Andrew Huberman_In loving memory of Nolan Williams (1982-2025):_ https://stan.md/3Qle2zp In this Huberman Lab Essentials episode, my guest is Dr. Nolan Williams, MD, a triple board-certified psychiatrist and neurologist. We discuss cutting-edge treat
Dave AspreyMicroplastics are building up inside your brain, blood, and reproductive tissue, and most detox protocols do nothing to remove them. This episode gives you the cellular science behind why toxins accumulate, which three detox pathways contro
Dr Jones DCBook your discovery call with the link below https://drjonesdc.com/ytl1d Dr. Jones, DC
Lifespan.ioLifespan.io's monthly digest covers the biggest moves in rejuvenation research for May 2026. Approaches that target the root causes of aging are now moving toward clinical trials.
Lifespan.ioHarvard's new "Pathways to Longevity" report introduces key longevity concepts to a general audience. It signals that the field has matured enough to move beyond academic journals.
Lifespan.ioScientists found that phosphatidylcholine — the most common lipid in mitochondrial membranes — drops with age. The decline appears to drive mitochondrial dysfunction, adding a new target for anti-aging research.
Longevity TechnologyInsideTracker has launched Terra, an AI-driven biomarker platform for wellness brands. The pivot reflects a broader shift: generic health claims no longer satisfy a market that wants measurable outcomes.
Longevity TechnologyNiagen Bioscience has renamed its external research program to align with its NAD+ (a compound linked to cellular energy and aging) focus. The program has now supported more than 300 collaborations and 45 peer-reviewed human studies.
Lifespan.ioScientists showed how early cancer cells change neighboring tissue to build a favorable niche for tumor growth. The finding could open new angles for early-stage cancer treatment.
Lifespan.ioScientists found that tau — a protein best known for its role in Alzheimer's disease — is also essential for forming long-term memory. The discovery may change how researchers approach tau-targeting therapies.
Research VialsA review of the leading peptides studied for immunomodulation — Thymalin, Selank, LL-37, KPV, and their distinct immune pathway targets.
Lifespan.ioA new study found that perimenopausal women had about twice the odds of poor cardiovascular health scores compared to premenopausal women, after adjusting for age. The window around menopause may be a critical intervention period.
BluePrint (Bryan Johnson)Bryan Johnson details the nine-step evening system behind his 99.4th-percentile sleep score. The post covers why his sleep prep starts at noon and which interventions moved the needle most.
Research VialsPart one of a three-part deep dive into peptides and cancer biology. It covers how tumors get started and which cellular pathways they exploit — essential background for anyone researching peptide safety or oncology applications.
Research VialsThe final installment addresses growth hormone secretagogues and cancer risk. It covers washout considerations and what the current evidence says about risk management in peptide research.
Peter AttiaA deep look at how sleep medications work, how to match a drug's pharmacology to a specific sleep problem, and what the evidence actually says about popular sleep supplements.
Nature AgingA Nature Aging study found that time-restricted feeding extended healthspan in both male and female C57BL/6J mice, and extended lifespan in males. The effect held in both sexes for health markers, adding to a growing body of evidence for feeding window timing.
Nature AgingNature Aging research identifies DREAM — a transcriptional repressor — as a link between how fast somatic mutations accumulate and how long an organism lives. It adds a new mechanistic angle to the aging-as-damage model.
Longevity TechnologyCambrian Bio will present Phase 1b results for ATX-304, an AMPK-activating compound, at the American Diabetes Association sessions in June 2026. AMPK (a cellular energy sensor) activation is a key metabolic target in longevity research.